n-(2-Aminoethyl)-2-nitrobenzene-1-sulfonamide hydrochloride, 98%, 5g

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate, 95%, 100mg

2-Bromo-3,3,3-trifluoro-1-propene>97.0%(GC)5g

2-Chloro-4-propionylpyridine, 97.0%, 1g

N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)butan-1-amine, 96%, 250mg

2-Amino-5-bromo-4-(trifluoromethyl)pyridine, 95.0%, 5g

2,2-Bis(4-acetoxyphenyl)propane>98.0%(GC)25g

(1-Methyl-1H-imidazol-2-yl)-oxo-acetic acid ethyl ester, 95.0%, 25g

7-(tert-Butyl) 2-methyl 3-bromo-7-azabicyclo[2.2.1]hepta-2,5-diene-2,7-dicarboxylate, 97%, 100mg

(S)-4-Boc-2-Hydroxymethyl-morpholine, 97.0%, 5g

[2,2'-Bipyridin]-4-amine, 97%, 5g

TERT-BUTYL ((1S,2S)-2-((3-CHLOROBENZYL)OXY)CYCLOHEXYL)CARBAMATE, 95.0%, 250mg

2,6-Dimethyl-3-hydroxypyridine, 95.0%, 250mg